16 October 2025
16 October 2025
With a legacy rooted in global scientific excellence, Sweden is quietly building one of Europe¡¯s most dynamic biotech ecosystems - despite lacking a big pharma anchor and facing persistent funding gaps.
A consortium led by Nordic Capital and Permira has raised its bid, though certain shareholder stances remain firm.
The funding will support the broadening of the company¡¯s ADC platform technologies.
The organisation calls for increased focus on neurological disorders like Alzheimer¡¯s disease, which could build on momentum set by the pharma industry.
If approved alongside current SoC maintenance therapies, Tukysa could become the first update to the regimen for HER2-positive breast cancer in over a decade.
With regard to deal volume, Houlihan Lokey topped by offering advisory services on 240 deals.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
